Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


04.09.2017

11 AIDS
4 AIDS Res Hum Retroviruses
1 Ann Intern Med
1 Curr Treat Options Neurol
3 HIV Med
2 J Acquir Immune Defic Syndr
2 J Infect Dis
1 J Med Virol
1 Lancet
2 Lancet HIV
2 Lancet Infect Dis
13 PLoS One
1 PLoS Pathog


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. BOCCARA F, Ghislain M, Meyer L, Goujard C, et al
    Impact of protease inhibitors on circulating PCSK9 levels in HIV-infected antiretroviral-naive patients from the ANRS COPANA cohort.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001633.
    PubMed     Text format     Abstract available

  2. FLORES HERRERA MF, Dauby N
    Eye compartmentalization of HIV replication and cataract risk in HIV-infected patients: is there a link?
    AIDS. 2017;31:2024-2025.
    PubMed     Text format    

  3. THIEBAUT R, Hue S, Le Marec F, Lelievre JD, et al
    Serum ST2 level is an independent predictor of all-cause mortality in HIV-infected patients. Aquitaine Cohort, France.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001628.
    PubMed     Text format     Abstract available

  4. ALVAREZ-DEL ARCO D, Fakoya I, Thomadakis C, Pantazis N, et al
    High levels of postmigration HIV acquisition within nine European countries.
    AIDS. 2017;31:1979-1988.
    PubMed     Text format     Abstract available

  5. RUBIN LH, Cook JA, Springer G, Weber KM, et al
    Perceived and post-traumatic stress are associated with decreased learning, memory, and fluency in HIV-infected women.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001625.
    PubMed     Text format     Abstract available

  6. ORLOVA-FINK N, Chowdhury FZ, Xiaoming S, Harrington S, et al
    Preferential susceptibility of Th9 and Th2 CD4 T cells to X4-tropic HIV-1 infection.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001630.
    PubMed     Text format     Abstract available

  7. WINTER JR, Stagg HR, Smith CJ, Brown AE, et al
    Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001635.
    PubMed     Text format     Abstract available

  8. MEDLAND NA, Nicholson S, Chow EPF, Read THR, et al
    Time from HIV infection to virological suppression: dramatic fall from 2007-2016.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001634.
    PubMed     Text format     Abstract available

  9. WEINSTEIN M, Yang OO, Cohen AC
    Were we prepared for PrEP? five years of implementation.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001626.
    PubMed     Text format     Abstract available

  10. RONIT A, Kristensen T, Klitbo DM, Gelpi M, et al
    Incidental lung cancers and positive computed tomography images in people living with HIV.
    AIDS. 2017;31:1973-1977.
    PubMed     Text format     Abstract available

  11. KLATT NR, Hunt PW
    MicroRNAs: novel tools to block gut inflammation in HIV?
    AIDS. 2017;31:2017-2018.
    PubMed     Text format    


    AIDS Res Hum Retroviruses

  12. YILDIZ SEVGI D, Gunduz A, Altuntas Aydin O, Mete B, et al
    Adherence to Antiretroviral Therapy in Turkey: Results from the ACTHIV-IST Study Group.
    AIDS Res Hum Retroviruses. 2017 Aug 30. doi: 10.1089/AID.2016.0266.
    PubMed     Text format     Abstract available

  13. LOEB STANGA L, Packel L, Martz T, Lemp G, et al
    The California HIV/AIDS Research Program: History, Impact, and HIV Cure Initiative.
    AIDS Res Hum Retroviruses. 2017 Aug 29. doi: 10.1089/AID.2017.0149.
    PubMed     Text format     Abstract available

  14. HEGEDUS A, Kavanagh Williamson M, Khan MB, Dias Zeidler J, et al
    Evidence for altered glutamine metabolism in HIV-1 infected primary human CD4+ T cells.
    AIDS Res Hum Retroviruses. 2017 Aug 26. doi: 10.1089/AID.2017.0165.
    PubMed     Text format     Abstract available

  15. ZHANG M, Xin R, Chang W
    A novel recombinant form of HIV-1 CRF01_AE/CRF07_BC identified by near full-length genome in Shaanxi, China.
    AIDS Res Hum Retroviruses. 2017 Aug 26. doi: 10.1089/AID.2017.0186.
    PubMed     Text format     Abstract available


    Ann Intern Med

  16. WALENSKY RP, Borre ED, Bekker LG, Hyle EP, et al
    Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid.
    Ann Intern Med. 2017 Aug 29. doi: 10.7326/M17-1358.
    PubMed     Text format     Abstract available


    Curr Treat Options Neurol

  17. AZIZ-DONNELLY A, Harrison TB
    Update of HIV-Associated Sensory Neuropathies.
    Curr Treat Options Neurol. 2017;19:36.
    PubMed     Text format     Abstract available


    HIV Med

  18. CUZIN L, Katlama C, Cotte L, Pugliese P, et al
    Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
    HIV Med. 2017;18:395-401.
    PubMed     Text format     Abstract available

  19. SHEPHERD L, Borges AH, Harvey R, Bower M, et al
    The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.
    HIV Med. 2017 Aug 31. doi: 10.1111/hiv.12546.
    PubMed     Text format     Abstract available

  20. HOFFMANN C, Welz T, Sabranski M, Kolb M, et al
    Reply to Letter 'Morning dosing for dolutegravir-related insomnia and sleep disorders' by Capetti et al.
    HIV Med. 2017 Aug 29. doi: 10.1111/hiv.12539.
    PubMed     Text format    


    J Acquir Immune Defic Syndr

  21. MARKOWITZ M, Grossman H, Anderson PL, Grant R, et al
    Newly Acquired Infection with Multi-Drug Resistant HIV-1 in a Patient Adherent to Pre-Exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Aug 26. doi: 10.1097/QAI.0000000000001534.
    PubMed     Text format    

  22. GOLDSTONE RN, Hasan SR, Goldstone SE
    Radiofrequency ablation therapy for anal intraepithelial neoplasia: results from a single-center prospective pilot study in HIV+ participants.
    J Acquir Immune Defic Syndr. 2017 Aug 26. doi: 10.1097/QAI.0000000000001535.
    PubMed     Text format     Abstract available


    J Infect Dis

  23. CLUTTER DS, Zhou S, Varghese V, Rhee SY, et al
    Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing.
    J Infect Dis. 2017;216:387-391.
    PubMed     Text format     Abstract available

  24. VAN LAARHOVEN A, Dian S, Ganiem AR, van Crevel R, et al
    Reply to Neeradi et al and Dhawan and Sankhyan.
    J Infect Dis. 2017;216:395-396.
    PubMed     Text format    


    J Med Virol

  25. DEHGHANI-DEHEJ F, Sarvari J, Esghaei M, Hosseini SY, et al
    Presence of Different Hepatitis C Virus Genotypes in Plasma and Peripheral Blood Mononuclear Cell Samples of Iranian Patients with HIV Infection.
    J Med Virol. 2017 Aug 28. doi: 10.1002/jmv.24925.
    PubMed     Text format     Abstract available


    Lancet

  26. GREEN A
    President of Zambia declares HIV testing mandatory.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32295.
    PubMed     Text format    


    Lancet HIV

  27. ROCHAT TJ, Stein A, Cortina-Borja M, Tanser F, et al
    The Amagugu intervention for disclosure of maternal HIV to uninfected primary school-aged children in South Africa: a randomised controlled trial.
    Lancet HIV. 2017 Aug 23. pii: S2352-3018(17)30133.
    PubMed     Text format     Abstract available

  28. CLUVER L, Sherr L
    Integrating disclosure support into family HIV care.
    Lancet HIV. 2017 Aug 23. pii: S2352-3018(17)30153.
    PubMed     Text format    


    Lancet Infect Dis

  29. YOON C, Semitala FC, Atuhumuza E, Katende J, et al
    Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.
    Lancet Infect Dis. 2017 Aug 25. pii: S1473-3099(17)30488.
    PubMed     Text format     Abstract available

  30. LOOKER KJ, Elmes JAR, Gottlieb SL, Schiffer JT, et al
    Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis.
    Lancet Infect Dis. 2017 Aug 23. pii: S1473-3099(17)30405.
    PubMed     Text format     Abstract available


    PLoS One

  31. STAFYLIS C, Klausner JD
    Evaluation of two 4th generation point-of-care assays for the detection of Human Immunodeficiency Virus infection.
    PLoS One. 2017;12:e0183944.
    PubMed     Text format     Abstract available

  32. MWAU M, Bwana P, Kithinji L, Ogollah F, et al
    Mother-to-child transmission of HIV in Kenya: A cross-sectional analysis of the national database over nine years.
    PLoS One. 2017;12:e0183860.
    PubMed     Text format     Abstract available

  33. PORTES SAR, Carvalho-Costa FA, Rocha MS, Fumian TM, et al
    Enteric viruses in HIV-1 seropositive and HIV-1 seronegative children with diarrheal diseases in Brazil.
    PLoS One. 2017;12:e0183196.
    PubMed     Text format     Abstract available

  34. RASHIDIAN H, Hadji M, Marzban M, Gholipour M, et al
    Sensitivity of self-reported opioid use in case-control studies: Healthy individuals versus hospitalized patients.
    PLoS One. 2017;12:e0183017.
    PubMed     Text format     Abstract available

  35. SUMANKUURO J, Crockett J, Wang S
    Maternal health care initiatives: Causes of morbidities and mortalities in two rural districts of Upper West Region, Ghana.
    PLoS One. 2017;12:e0183644.
    PubMed     Text format     Abstract available

  36. MASSON JJR, Murphy AJ, Lee MKS, Ostrowski M, et al
    Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy.
    PLoS One. 2017;12:e0183931.
    PubMed     Text format     Abstract available

  37. MUNOZ-MORENO JA, Prats A, Molto J, Garolera M, et al
    Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study.
    PLoS One. 2017;12:e0182547.
    PubMed     Text format     Abstract available

  38. NANCE N, Pendo P, Masanja J, Ngilangwa DP, et al
    Short-term effectiveness of a community health worker intervention for HIV-infected pregnant women in Tanzania to improve treatment adherence and retention in care: A cluster-randomized trial.
    PLoS One. 2017;12:e0181919.
    PubMed     Text format     Abstract available

  39. JIAO B, Rosen Z, Bellanger M, Belkin G, et al
    The cost-effectiveness of PHQ screening and collaborative care for depression in New York City.
    PLoS One. 2017;12:e0184210.
    PubMed     Text format     Abstract available

  40. ANDREATOS N, Grigoras C, Shehadeh F, Pliakos EE, et al
    The impact of HIV infection and socioeconomic factors on the incidence of gonorrhea: A county-level, US-wide analysis.
    PLoS One. 2017;12:e0183938.
    PubMed     Text format     Abstract available

  41. AGOLORY SG, Auld AF, Odafe S, Shiraishi RW, et al
    High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    PLoS One. 2017;12:e0183823.
    PubMed     Text format     Abstract available

  42. LIU H, Shen W, Shu J, Kou Z, et al
    A novel polyepitope vaccine elicited HIV peptide specific CD4+ T cell responses in HLA-A2/DRB1 transgenic mice.
    PLoS One. 2017;12:e0184207.
    PubMed     Text format     Abstract available

  43. MORSICA G, Bagaglio S, Spagnuolo V, Castagna A, et al
    Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.
    PLoS One. 2017;12:e0184128.
    PubMed     Text format     Abstract available


    PLoS Pathog

  44. HOTTER D, Krabbe T, Reith E, Gawanbacht A, et al
    Primate lentiviruses use at least three alternative strategies to suppress NF-kappaB-mediated immune activation.
    PLoS Pathog. 2017;13:e1006598.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: